GIST Clinical Trials

 First | Previous | Page 2 of 2

   
Phase 2

Intervention:  
Imatinib
Status:  
Recruiting
Phase 1

Intervention:  
Dendritic Cell Vaccine
Status:  
Recruiting
Phase 1

Intervention:  
ARQ 092
Status:  
Recruiting
Phase 2

Intervention:  
LOX0-101
Status:  
Recruiting
Phase 2

Intervention:  
Entrectinib
Status:  
Recruiting
Phase 3

Intervention:  
Crenolanib (CP-868,596)
Status:  
Recruiting